Despite strong prior evidence that this SNP may play a role women's cancer susceptibility, we conclude that variation in TCF7L2 is not likely to be associated with risk of non-familial breast cancer or ovarian cancer. Here, TCF7L2 is linked to ovarian carcinoma.